> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Field Correction on Altitude-affected Balloon Pumps
- URL: https://www.fdaweb.com/field-correction-on-altitude-affected-balloon-pumps/
- Published: 2018-09-20T12:00:00.000Z
- Updated: 2026-09-15T00:33:12.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5142411

Getinge has begun a field correction on about 5,223 Maquet/Getinge Cardiosave intra-aortic balloon pumps (IABP) sold by Datascope Corp. due to a potential interruption or inability to start therapy. The issue involves certain intra-aortic balloons prior to or during the use with Cardiosave IABP for users who are at altitudes above 3,200 feet/975 meters. This condition could potentially lead to patient hemodynamic instability, a [recall notice](https://www.example.com/?utm%5Fcampaign=Getinge%20Issues%20Worldwide%20Voluntary%20Correction%20of%20Maquet%2FGetinge%20Cardiosave%20Intra-Aortic%20Balloon%20Pump&utm%5Fmedium=email&utm%5Fsource=Eloqua&elqTrackId=70789C09321116333CA3EB7FA549CAD9&elq=012090872f55) says. Maquet/Getinge is currently developing a software correction to address the altitude issue, which should be available 2/2019.